O
Optio RX
Premier national pharmacy offering specialized therapies for humans and pets, ensuring well-being and quality care
About Optio RX
OptioRx is a leading national pharmacy specializing in providing advanced therapies for both humans and pets. The company operates in the healthcare market, focusing on delivering high-quality, compounded medications that meet the specific needs of patients. OptioRx serves a diverse clientele, including individual patients, families, and healthcare providers, by offering tailored therapeutic solutions that enhance well-being and improve the quality of care. The business model revolves around partnering with medical providers to continuously innovate and adapt to changing patient needs and expectations. Revenue is generated through the sale of specialized medications and therapeutic services, ensuring convenience and speed to therapy nationwide. OptioRx is committed to principles of trust, honesty, respect, integrity, and commitment, fostering a work environment that values diversity and enhances the quality of life for its team members.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Palm Beach Gardens, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Capitala Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Optio RX on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Optio RX on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.